A small animal model that could be infected with human immunodeficiency virus 1 (HIV-1) after peripheral inoculation would greatly facilitate the study of the pathophysiology of acute HIV-1 infection. The utility of SCID mice implanted with human fetal thymus and liver (SCIDhu mice) for studying peripheral HIV-1 infizction in vivo has been hampered by the requirement for direct intraimplant injection of H1V-1 and the continued restriction of the resultant HIV-1 infection to the human thymus and liver (hu-thy/liv) implant. This may have been due to the very low numbers of human T cells present in the SCID-hu mouse peripheral lymphoid compartment. Since the degree of the peripheral reconstitution of SCID-hu mice with human T cells may be a function of the hu-thy/liv implant size, we increased the quantity of hu-thy/liv tissue implanted under the renal capsule and implanted bu-thy/liv tissue under the capsules of both kidneys. This resulted in SCID-hu mice in which significant numbers of human T cells were detected in the peripheral blood, spleens, and lymph nodes. After intraimplant injection of HIV-1 into these modified SCID-hu mice, significant HIV-1 infection was detected by quantitative coculture not only in the hu-tby/liv implant, but also in the spleen and peripheral blood. This indicated that HIV-1 infection can spread from the thymus to the peripheral lymphoid compartment. More importantly, a similar degree of infection of the hu-thy/liv implant and peripheral lymphoid compartment occurred after peripheral intraperitoneal inoculation with HIV-1. Active viral replication was indicated by the detection of HIV-1 gag DNA, HIV-1 gag RNA, and spliced tat/rev KNA in the hu-thy/liv implants, peripheral blood mononudear cells (PBMC), spleens, and lymph nodes of these HIV-l-infected SCID-hu mice. As a first step in using our modified SCID-hu mouse model to investigate the pathophysiological consequences of HIV-1 infection, the effect of HIV-1 infection on the expression of human cytokines shown to enhance HIV-1 replication was examined. Significantly more of the HIV-l-infected SCID-hu mice expressed mKNA for human tumor necrosis factors c~ and/5, and interleukin 2 in their spleens, lymph nodes, and PBMC than did uninfected SCID-hu mice. This suggested that HIV-1 infection in vivo can stimulate the expression of cytokine mP, NA by human T cells. Our modified SCID-hu mice may provide an improved model for studying the pathophysiology of HIV-1 infection in vivo and for investigating the effects of anti-HIV interventions on the prevention of disseminated HIV-1 infection.
s exposure of an individual to an inoculum of HIV-1, an infectious cycle is initiated that leads to systemic dissemination of HIV-1 and HIV-l-infected cells into lymphoid organs (1) . The subsequent disease course may be determined by the sites to which HIV-1 is seeded during the acute stage of infection (1, 2) . The generation of immune responses directed against HIV-1 may result in a prolonged period of clinical latency (2) . However, a quiescent state of HIV-1 disease in the peripheral blood is often accompanied by ongoing active and progressive HIV-1 infection in lymphoid organs (3) (4) (5) . Thus, examination of the peripheral blood of HIV-1-infected individuals does not detect the high degree of covert HIV-1 replication taking place in lymphoid tissues (6) . Investigation of the pathophysiology of acute HIV-1 infection in humans is therefore restricted by the limited sampling of lymphoid organs during this stage. SCID mice implanted with human fetal thymus and liver (SCID-hu mice) 1 are an attractive small animal model for studying in vivo HIV-1 infection (7). However, so far, HIV-1 infection of the human fetal thymus and liver (hu-thy/liv) implanted in these mice has only been reported to occur after direct intraimplant injection of HIV-1 and the resultant HIV-1 infection was restricted to the hu-thy/liv implant (8) . In this report we describe a modified SCID-hu mouse model in which disseminated HIV-1 infection occurs in the peripheral mouse lymphoid organs and the hu-thy/liv implant after peripheral inoculation with HIV-1.
Materials and Methods

Implantation of Huraan Tt~mic and Liver Tissue Into SCID Mice.
Human fetal thymic and liver tissue were obtained from 17-21 gestational week fetuses after the elective termination of pregnancy and implanted into SCID mice (6-8-wk-old) within 8 h of avaihbility as described (9) . Briefly, the fetal thymus was cut into pieces ('~0.3 era ~) along the grossly visible lines of thymic lobules and the fetal liver was cut into pieces ('~0.5 cm 3) and kept in ice-cold PBS until implantation. While kept on ice, the human fetal thymus and liver pieces described above were cut into 1-mm 3 pieces and then approximately 10 pieces of each were loaded into a 16-gange needle with a rounded tip. The SCID mice were anesthetized with Pentobarbital (40-80 mg/kg), the left and right kidneys were sequentially exteriorized, a 0.5-mm incision was made in each kidney capsuh, and the 10 pieces of thymus and liver tissue obtained from the same donor were imphnted underneath the capsule using the 16-gauge needle. After surgery, minimal morbidity and mortality was observed. 3 mo after implantation, ;>95% of the grafts took and increased in size to >5 x 10 x 5 ram. The histological appearance of the graft resembled that of normal human thymus and the expected thymocyte subpopulations were observed by flow cytometry as described (9) . All tissue used came from HIV-1 seronegative donors. The consent forms and procedures used in this study were reviewed and approved by the Albert Einstein College of Medicine Committee on Cliuical Investigation.
Flow CytometricAnalysis. Mononuclear ceUs were harvested from the peripheral blood, spleens, and LN of the SCID-hu mice and stained with PE-, FITC, or peridinin chlorophyll protein-conjugated mouse mAb to human CD4 (Leu 3a, Becton Dickinson, Mountain View, CA), human CD8 (l.eu 2a, Becton Dickinson), human CD3 (I.eu 4, Becton Dickinson), or human CD45 as described (9) . TCK V gene expression was analyzed by staining mononuclear cells with PerCP-conjugated mouse mAb to human CD4 (Leu 3a), PE-conjugated mouse mAb to human CD8 (l.eu 2a), and FFIC-conjugated mouse mAb to either TCR Vfl2, VflSa, Vfl5b, V85c, Vfl6, Vfl8, Vf112, Vf119, or Vot2 (T Ceil Diagnostics, Cambridge, MA). Expression of human CD45, CD3, CD4, or CD8 or human CD4, CDS, and TCR V genes by lymphocytes present in the SCID-hu mice were then assessed by three-color flow cytometric analysis using a FACSc.an | cell analyzer with LYSIS-II software (Becton Dickinson). Nonviable cells and unlysed RBC were gated out based on their forward and side scatter profiles, and lymphocyte gates 1 Abbreviations used in this paper: flz-MG, flz-microglobulin; hu-thy/liv, human fetal thymus and fiver; SCID-hu, SCID mice implanted with human fetal thymus and fiver.
were set on the basis of forward and side scatter profiles to correspond to gates set to control human (from healthy adult volunteer) lymphocytes. Cut-off values for the quadrants were set after compensation for PE vs. FITC vs. PerCP emission based on the analysis of single, double, and triple staining of positive and negafive control samples (human adult and C.B-17 mouse mononudear cells) and of the appropriate mouse IgG isotype controls.
Infection of SCID-hu Mice with HII/=L The patient isolate of HIV-1 used in this study, HIV-I~, was obtained after coculture of PBMC isolated from a 2-yr-old HIV-l-infected child with PHAactivated donor PBMC as described (10) . The initial coculture supernatant was harvested and cocultured with PHA-activated PBMC to expand the quantity of HIV-I~. The secondary coculture supematant was harvested and aliquots were frozen in liquid nitrogen. The tissue culture infective doses0 (TCIDs0) of the supernatant was determined by culturing titered dilutions of a thawed aliquot with PHA-activated donor PBMC (106) in a total vohme of 2.0 ml of RPMI 1640 with FCS (10% vol/vol) and Ib2 (32 U/ml). After 2 wk of culture, the p24 antigen content of the culture supematam was measured by using the HIV-1 p24 core profile ELISA assay (Dupont-NEN, Wilmington, DE). The lowest dilution of supernatant that infected at least half of the quadruplicate cultures with HIV-1 was taken as the end point or TCIDs0. SCID-hu mice were infected either by direct injection of 300 TCIDs0 of HIV-lzs in a volume of 30 #1 into one hu-thy/liv implant or by intraperitoneal injection of 8,000 or 800 TCIDs0 of HIV-12s in a volume of 8OO #1.
HIV Viral Culture. The titer of HIV-l-infected mononuclear cells present in the peripheral blood, spleens, thymic implants, and LN of the SCID-hu mice, was determined as described (11, 12) . Fivefold dilutions of PBMC ranging from 10 ~ cells to 3.2 x 10 ~ were cultured at 37~ in quadruplicate cultures in 24-weR culture plates with PHA-activated donor mononudear cells (106) in a total vohime of 2.0 ml of RPMI 1640 with added FCS (10% vol/vol) and IL-2 (32 U/ml). After 1-2 wk of culture, the p24 antigen content of the culture supematant was measured as described above. The lowest number of added PBMC that infected at least half of the quadruplicate cultures with HIV-1 was taken as the end point or TCID and the data are presented as TCID/10 ~ PBMC (11) .
HIVl-specific DNA and RNA PCR. The presence of HIV-1 DNA and RNA gag-encoded sequences and spliced tat/rev mRNA sequences were assessed by PCK as described (13, 14) . Briefly, mononuclear ceils from the SCID-hu mice were lysed in gnanidine isothiocyanate (4 M) buffer, cellular DNA and RNA were separated by cesium chloride (5.7 M) density gradient centrifugation and precipitated with ethanol. For DNA PCR, the HIV-1 DNA (1 #g) was amplified for 35 cycles with a primer pair specific for the gag gene segment (SK38/39), electrophoresed through 1.5% NuSieve/0.5% SeaKem agarose (FMC Corp. BioProducts, Rockland, ME) gel containing ethidiura bromide, and the amplified product was detected under ultraviolet light. HIV-1 RNA was detected by PCR amplification of reverse transcribed RNA (RT-PCR) as described (13) . Briefly, after treatment of the cellular RNA with RNase-free DNase (Boehringer Mannbeim, Indianapolis, IN), RNA (7 #g) in 7 #1 of ddHaO was mixed with 4 #1 of 5 x buffer (250 mM Tris-HCl, pH 8.3/375 raM KC1/15 mM MgCh), 2 #1 dithiothreitol (100 raM), 1 #1 of random heaamers (GIBCO BRL, Gaithersburg, MD) and 5 #1 mixed dNTPs (2 raM each). Samples were mixed, heated to 65~ for 10 min, cooled on ice for 5 min and then 1 #1 (200 U) of Superscript reverse transcriptase (GIBCO BRL) was added. This final reaction mixture was vortexed, briefly spun down, incubated at 37~ for 60 rain, and then placed on ice. HIV-1 eDNA was amplified either with SK38/39 or a primer pair specific for tat/rev-spliced mRNA sequences (TR-5/TR-3). Specifidty of the amplified product was confirmed by hybridization of a Southern blot of the amplified DNA and cDNA with a 3"-[32p]ATP--labeled internal probe specific for the SK38/39 product (SK19) or the TR-5/TR-3 product (TR-4). A given sample was regarded as positive ff PCIL amplification resulted in a DNA product of the predicted size that hybridized to the specific internal probe. Positive and negative controls were included in all runs and, to prevent contamination, suggested guidelines for PCR quality control were followed (15) . For RT-PCR, the absence of residual DNA template was verified by the absence of an amplified product after PCR amplification of DNase-treated samples that had not been reverse transcribed.
Detection of Human Cytokine Gene Expression b,/ RT-PCR.
The pattern of in vivo human cytokine expression of the human cells present in SCID-hu mice was assessed by using a modification of a previously described technique (16) . To ensure that the PCR amplification product was of human origin, we designed the primers so that the nucleotide sequence of the 3' end was complementary to a human cytokine cDNA sequence that was not present on the mouse cytokine cDNA. Derivation of the PCR product from mRNA was insured by designing primer pairs that yidded an amplification product that spanned exon-exon junctions. After reverse transcription of total RNA (7/~g) extracted from the huthy/liv implant, PBMC, spleen, and LN of the SCID-hu mice, cDNA was amplified by PCR with human cytokine-specific primers for 60 cycles of denaturation at 94~ for 1 rain, annealing at 65~ for I rain, and extension at 72~ for 1 rain. The presence of the target mRNA was indicated by the presence of an amplification product of the predicted size after fractionation of the PCR products by electrophoresis and ethidium bromide staining. The primer pairs for each cytokine were selected from published DNA sequences based on previously described guidelines (17) . The nuclcotide sequences for 5' and 3' primers respectively were:/~z-microglobulin (/~2-MG), TC~CTTGAGGCTATCCAGCGT and GTGGTT-CACACGGCAGC~ATACTC; IL-2, CATTGCACTAAGTCT-TCK2AC'I'IGCACTIGTCACA and ~GTCCCT-GC~TCTT; IL-4, CTCACAGAGCAGAAGACTCTG'ICK2 and AAGCCCGCCAGC~CCCAGAGGTICC3~ IL-6, TAC~CCTC-GACGGCATCTCAGCCC and CTGGTTCTGTC~C33GCAG-CTTCGTCAGC; TNF-~, CGCTCCCCAAGAAGACAGGGG-GCC and GATGGCAGAGAGGAGGTTGACCTIGGT; TNF-~, CCCA~CC'TC~TGTTG and G'IGC~TGGATAGC"I~ GTCTCCCTC, C,G. The amplification product for each primer pair was confirmed by demonstrating hybridization of an internal probe to the predicted PCR amplification product after Southern blotting. Human specificity for each primer pair was verified by demonstrating that amplification of the predicted product did not occur after RT-PCR of RNA extracted from mouse mitogen-activated mononuclear ceUs. ALl samples were analyzed by RT-PCR for the presence of mouse or human/~2-microglobulin to verify the integrity of the sample mRNA and the e~ciency of subsequent reverse transcription. Positive and negative controls were included in all runs and suggested guidelines for PCR quality control were foUowed as described above.
Results
tYripheral Reconstitution of SCID-hu Mice with Human T Cell.~ We had previously observed a correlation between the number of human T cells present in the peripheral blood of SCID-hu mice and the degree of growth of the implanted hu-thy/liv. Therefore, in order tO increase the number of human T cells present in the periphery of SCID-hu mice, we increased the quantity of hu-thy/liv tissue implanted under the renal capsule and implanted hu-thy/liv tissue under the capsules of both kidneys. 3 mo after implantation, the number of human T cells present in the peripheral lymphoid compartment of SCID-hu mice constructed in this fashion was evaluated by three-color flow cytometric analysis of lymphocytes in the peripheral blood, LN, and spleens for the expression of human CD45, CD3, CD4, and CD8 and representative two-dimensional dot histograms are shown in Fig. 1 . Examination of human CD4 and CD8 expression by lymphocytes positive for human CD45 in SCID-hu mice constructed in this fashion revealed that in the peripheral blood (n = 25), 4.06 _+ 0.49% were CD4 + and 1.34 _ 0.20% were CD8 +, in the spleen (n = 7), 4.91 + 2.04% were CD4 +, and 2.93 +_ 1.21% were CD8 +, and in the LN (n = 7), 8.64 + 3.93% were CD4 + and 3.47 _+ 1.38% were CD8 +. To determine whether human T cells were present in the peritoneal cavity of these SCID-hu mice, peri- ~:...
3.3
FL3-H\CD 4 PRCP --) toneal exudate cells were harvested by peritoneal lavage with cold PBS, assessed for the expression of human CD45, CD4, and CD8, and representative two-dimensional dot histograms are shown in Fig. 2 . As determined by three-color flow cytometric analysis of peritoneal exudate cells, 4.13 + 3.84% of the peritoneal exudate cells in SCID-hu mice (n = 3) were human CD45+CD4 + lymphocytes and 1.24 _+ 1.08% were human CD45+CD8 + lymphocytes. The diversity of the human T cells present in the periphery of SCID-hu mice was assessed by examining their expression of TCR Vfl genes after staining with a panel of TCR Vflspecific mAb that recognize about 30% of the peripheral human T cell population. As shown in Figure 3 , a diverse population of human TCR Vfl subsets were observed in the periphery of SCID-hu mice. Thus, construction of SCID-hu mice in this fashion results in the significant reconstitution of the peripheral lymphoid compartment with a broad spectrum of human T cells.
Infection of the Peripheral Lymphoid Compartment of SCID-hu Mice with HIV-1.
After direct inoculation of the hu-thy/liv implant with HIV-1, the SCID-hu mice were assessed for disseminated HIV-1 infection. Since hu-thy/liv was implanted in each kidney capsule of these SCID-hu mice, we could assess whether HIV-1 directly injected into the hu-thy/liv implanted in one kidney capsule could be systemically disseminated and infect the other hu-thy/liv implanted in the opposite kidney capsule. HIV-1 could be isolated by coculture of thymocytes from both the hu-thy/liv implants, and the splenocytes of SCID-hu mice 1 mo after direct unilateral HIV-1 inoculation into hu-thy/liv implants. The degree of HIV-1 infection present in the HIV-l-injected hu-thy/liv implant, the uninjected hu-thy/liv implant in the opposite kidney, the spleen, and PBMC was determined by quantitative coculture (Table 1) PBMC obtained from the peripheral blood of three of these intraimplant-injected SCID-hu mice. Thus, T cells that become infected with HIV-1 in the hu-thy/liv implant can induce disseminated HIV-1 infection of SCID-hu mice that were constructed as described above.
To examine the capacity of HIV-1 to infect SCID-hu mice by other routes, HIV-1 was inoculated into the peritoneal cavity of SCID-hu mice. I mo after HIV-1 inoculation, HIV-1 was isolated by coculture from the hu-thy/liv implants of five of five SCID-hu mice injected with 8,000 TCIDs0, one of two SCID-hu mice injected with 800 TCIDs0, and zero of two SCID-hu mice injected with 80 TCIDs0. We confirmed that the HIV-1 isolated was not residual virus from the initial inoculation by demonstrating that no HIV-1 was isolated by coculture from the spleens of unimplanted SCID mice 1 mo after injection with 8,000 TCIDs0 of HIV-12s. Assessment of the extent of HIV-1 infection by quantitative coculture indicated that the HIV-1 infection in the hu-thy/liv implant ranged from 625 to >3,125 TCID/106 cells (Table  2) , comparable to that which occurred after intraimplant infection of SCID-hu mice. HIV-1 infection ranging from >0.7 to 25 TCID/106 cells was also detected in four of five spleens from the inoculated SCID-hu mice. In addition, the peripheral blood of two SCID-hu mice assessed contained >2 and >5 TCID/106 cells. Thus, after peripheral inoculation with HIV-1, HIV-l-infected cells or HIV-1 can migrate from the periphery into the hu-thy/liv implant and infect human T cells present in the implant.
Detection of HIV-1 DNA and RNA in HIV-l-infected SCID-hu Mice. The presence of HIV-1 DNA and RNA in the hu-thy/liv implants, and the peripheral lymphoid compartment of the SCID-hu mice infected by inoculation of HIV-1 either into the hu-thy/liv implant or peritoneal cavity were assessed by PCR. HIV-1 gag DNA was detected by SK38/39-primed PCR amplification in the hu-thy/liv im- T1  >3,125  ND"  5  ND  T2  >3,125  ND  >2  ND  T3  >3,125  >3,125  333  >2  T4  >3,125  0  2  >1  T5  >3,125  >3,125  >2  >1 3 mo after implantation under the renal capsule of SCID mice, a hu-thy/liv implant in five SCID-hu mice was injected with 300 TCIDs0 of HlV-lzs. 1 mo later, the mice were killed, mononuclear cells were isolated from the injected hu-thy/liv, the uninjected hu-thy/liv implanted in the opposite kidney, the spleen, and the peripheral blood, extensively washed and, if suffldent ceils were available, quantitative coculture of mononuclear cells with PHA-activated PBMC (104) was performed. After 7 d of culture, an aliquot of the supernatant was harvested and assessed for the presence of p24 antigen. The coculture was considered positive if >100 pg/ml of p24 antigen was detected in the supernatant. The data are presented as TCID/104 mononuclear cells and ")" indicates that the coculture was positive for the lowest number of cells added. * Not done.
plant, PBMC, spleen, and LN of SCID-hu mice infected with HIV-1 either by intraimplant injection (Fig. 4 A) or by intraperitoneal inoculation (Fig. 4 B) . In addition, HIV-1 gag R N A was detected by SK38/39-primed R T -P C R in the huthy/liv implant, PBMC, spleen, and LN of SCID-hu mice infected with HIV-1 either by intraimplant injection (Fig.  4 C) or by intraperitoneal inoculation (Fig. 4 D) . To determine whether ongoing viral replication was occurring in the HIV-l-infected SCID-hu mice, the expression oftat/rev spliced TCIDs0 (PI, P2, P4, and P5) or 8.0 x 103 TCIDs0 (P3) of HIV-12s, the mice were killed, mononudear ceils were isolated from the hu-thy/liv implant, the spleen, and the peripheral blood, extensively washed and, ff suf~dent ceils were available, quantitative coculture of the mononuclear cells with PHA-activated PBMC (104) was performed. After 7 d of culture, an aliquot of the supernatant was harvested and assessed for the presence of p24 antigen. The coculture was considered positive if )100 pg/ml of p24 antigen was detected in the supernatant. The data are presented as TCID/106 mononuclear ceils and ")" indicates that the coculture was positive for the lowest number of added cells. * Not done. m R N A was examined. The presence of tat/rev mR.NA was detected by R T -P C R in the hu-thy/liv implant, PBMC, spleen, and LN of SCID-hu mice infected with HIV-1 either by intraimplant injection (Fig. 4 E) or by intraperitoneal inoculation (Fig. 4 F) . HIV-1 DNA and eDNA was detected in the spleens of unimplanted SCID mice 1 mo after injection with 8,000 TCIDs0 of HIV-lzs (data not shown). Thus, productive infraction with HIV-1 and active viral replication was occurring in the periphery of SCID-hu mice infected by inoculation of HIV-1 either into the hu-thy/liv implant or into the peritoneal cavity. Since human CD4 + T cells were present in the peritoneal cavity of these SCID-hu mice, we examined whether they became infected with HIV-1 after intraperitoneal injection. After intraperitoneal injection of HIV-lzs (8,000 TCIDs0), peritoneal exudate cells were harvested, extensively washed, and their DNA was extracted. As shown in 
Expression of Human Cytokine Genes in HIV-l-infected SCID-hu Mice.
Since cytokines such as TNF-ol, TNF-~, IL-2, IL-4, and IL-6 can modulate HIV-1 replication in vitro (2), human cytokine mlkNA expression in the hu-thy/liv implant, spleen, LN, and PBMC of SCID-hu mice was analyzed by RT-PCR with human mRNA-specific cytokine primers. The detection of human B2-MG mRNA indicated that human cells were present throughout the peripheral lymphoid compartment of HIV-1-infected SCID-hu mice; however, differences in human cytokine mRNA expression by human cells present in different regions were observed (Fig.  6) . Analysis by IkT-PCR detected the expression of TNF-ol mRNA in the hu-thy/liv implant and spleen; TNF-B mRNA in the hu-thy/liv implant, spleen, and PBMC; IL-2 mRNA in the hu-thy/liv implant and spleen; and IL-4 and IL-6 mRNA in the hu-thy/liv implant. To assess the effect of HIV-1 infection on cytokine expression in SCID-hu mice, we compared the expression of human mRNA encoding TNF-o~, TNF-B, IL-2, IL-4, and IL-6 in the hu-thy/liv implant, PBMC, spleens and LN of eight SCID-hu mice and seven HIV-i-infected SCID-hu mice. In the seven HIV-l-infected mice, active HIV-1 infection was demonstrated by the detection of tat/rev mRNA in seven out of seven of the hu-thy/liv implants, seven out of seven spleens, six out of seven PBMC, and six out of seven LN (Fig. 7) . Expression of TNF-ol, TNF-B, and IL-2 mRNA was increased in the PBMC (Fig.  7 B) , LN (Fig. 7 C) , and spleens (Fig. 7 D) of the HIV-1-infected SCID-hu mice. For eaample, whereas TNF-ot, TNF-B and IL-2 mRNA was detected in the spleens of one of eight, five of eight, and one of eight SCID-hu mice, respectively, they were detected in the spleens of five of six, six of six, and three of six HIV-1-infected SCID-hu mice, respectively. Taken together, this data suggests that HIV-1 infection in vivo can stimulate cytokine production by human T cells.
Discussion
Previous reports using SCID-hu mice demonstrated that HIV-1 infection occurred exclusively in the implanted human organs and HIV-1 infection of the hu-thy/liv implant was only observed after direct injection into the implant (8) . We demonstrated in our modified mouse model that after intraperitoneal or intraimplant injection of HIV-1 into SCID- hu mice, significant HIV-1 infection occurred not only in the implant, but also in peripheral tissues. Furthermore, the presence of HIV-1 gag DNA, HIV-1 gag RNA, and spliced tat/rev RNA in the hu-thy/liv implants, PBMC, spleens, and LN of HIV-l-infected SCID-hu mice indicated that disseminated, active HIV-1 infection occurred in SCID-hu mice after transmission of HIV-1 by intraimplant injection, as well as by intraperitoneal inoculation.
In the SCID-hu model reported by Krowka et al. (18) , peripheral HIV-1 infection after inoculation into the hu-thy/llv implant may have been precluded by the presence of a mean level of only 0.7% of human T cells in the peripheral blood and very low levels of human cells in the spleens of the SCID-hu mice used. The original SCID-hu mice were constructed by implanting one to two fragments of human fetal thymus and liver under the capsule of one kidney in SCID mice (19) . To augment the number of human T cells present in the periphery of SCID-hu mice, we increased the quantity of hu-thy/liv tissue implanted under the renal capsule and implanted hu-thy/liv tissue under the capsules of both kidneys. In 25 SCID-hu mice constructed in this manner, a mean of 6.4% ofthdr PBL were human T cells (4.06 _+ 0.49% human CD4 + T cells and 1.34 + 0.20% human CD8 + T cells). It is possible that other variables such as the viability of the implanted fetal tissue or the implantation technique used may have also contributed to the increased engraftment of the peripheral lymphoid compartment that we observed.
After injection of the hu-thy/liv implant in the SC/D-hu mice constructed in this fashion with HIV-1, systemic infection of the implants, spleens, LN, and PBMC with HIV-1 was observed. This indicated that human T cells can become infected with HIV-1 while maturing in the thymus, exit the thymus, migrate to the periphery, and then possibly infect T cells present in the peripheral blood, spleen, and LN. The observation that the HIV-1 hu-thy/liv infection on one side was spread to the hu-thy/liv implanted in the opposite kidney suggested that free HIV-1 or HIV-l-infected ceils from the periphery can recirculate and infect the hu-thy/liv implant on the opposite side. This assumption was confirmed by our observation that the hu-thy/liv implant could also be infected after intraperitoneal HIV-1 inoculation.
To determine whether free HIV-1 virus could infect the hu-thy/liv implant, we intravenously injected 8 x 104 TCIDs0 of HIV-lzs into these SCID-hu mice (data not shown). No HIV-1 infection occurred in these SCID-hu mice, suggesting that the major route of HIV-1 dissemination occurred via HIV-l-infected cells and not via blood-mediated transfer of HIV-1 during intrathymic injection or via secondary viremia. In our SCID-hu mouse model, human CD4 + T cells were present in the peritoneal cavity and draining LN, and HIV-1 infection in these ceils was detected by DNA PCR. Thus, it is possible that the first stage after intraperitoneal HIV-1 inoculation involves local infection of these human CD4 + cells with HIV-1. Subsequently, these HIV-l-infected cells may migrate throughout the periphery and mediate HIV-1 infection of the spleens, LN, and huthy/liv implants. Although the majority of T cell circulation is usually unidirectional from the thymus to the periphery, activated T ceils can migrate from the periphery to the thymic medulla (20) (21) (22) . Since HIV-1 preferentially infects activated T cells (23) , an intriguing possibility is that T cells infected with HIV-1 in the periphery migrate back to the thymus and thereby induce extensive HIV-1 infection of the thymus. Taken together, these data suggest that the human fetal thymus may serve as a reservoir for HIV-1 infection and mediate subsequent seeding of the periphery with HIV-l-infected T ceils.
The capacity of cytokines such as TNF-ot, TNF-/3, and IL-6 to stimulate HIV-1 replication in cultured monocytes and T cells has been demonstrated (2) . In addition, IL-2 and IL-4 synergistically promote HIV-1 replication in cultured thymocytes (24) , and IL-6 secreted by thymic epithdial cells upregnlate HIV-1 replication in chronically infected ceils (25) . To assess the function of peripheral human T cells in SCID-hu mice and the in vivo role of cytokines in HIV-1 replication, the production of human cytokine mKNA in the hu-thy/liv implant and periphery of SCID-hu mice was assessed by KT-PCK. The mKNA for TNF-cx, TNF-/3, IL-2, IL-4, and IL-6 was detected in all of the hu-thy/liv implants and expression of the mKNA for TNF-c~, TNF-fl, IL-2, and IL-4 was detected in the spleens, LN, and PBMC of some SCID-hu mice. HIV-1 infection in the hu-thy/liv implant of mice infected with HIV-1 by intraimplant and by intraperitoneal injection was, as shown by quantitative coculture, at least 100-fold greater than that detected in the peripheral routine lymphoid organs of infected SCID-hu mice. The augmented degree of HIV-1 replication in the thymic implant may be related to the increased cytokine expression observed in the implants. After HIV-1 infection, an increased expression of TNF-ot, TNF-/3, and IL-2 mKNA was observed in the peripheral lymphoid compa~-tctlent of HIV-l-infected mice_ Although HIV-1 infection in vitro may be enhanced by the presence of these cytokines, in vivo HIV-1 replication may not require their presence. This was indicated by the observation that expression of mKNA for TNF-ot, TNF-/3, IL-2, and IL-4 was not detected in three of six LN wherein the detection of tat/rev mKNA indicated that active HIV-1 replication was occurring. Since expression by human T cells of mKNA for TNF-c~ (26), TNF-/3 (27) , and IL-2 (28) are increased after activation, the data in this report indicated that HIV-1 infection may induce in vivo T cell activation. This is compatible with the recent observation that in vitro HIV-1 infection activates TNF-c~ and TNF-/3 gene expression via the HIV-1 transactivating Tat protein (29) . Therefore, the use of species-specific cytokine KT-PCK in these SCID-hu mice should provide a valuable modal for exploring the in vivo role of cytokines in HIV-1 infection.
Recently it was shown that HIV directly injected into huthy/liv implants in SCID-hu mice induces depletion of thymocytes (30, 31) . We did not observe this degree of suppression of thymopoiesis 1 mo after infection of the thymic implants of our SCID-hu mice with HIV-t2s. This discrepancy most likely is related to the variable pathogenesis of different HIV-1 isolates as observed by Bonyhadi et al. (30) . Variability in the behavior of thymic infection with different HIV-1 strains could also account for the observation that only two of three HIV-l-infected thymuses obtained from human abortuses were histologically abnormal (32) .
Although the behavior of HIV-1 in SCID-hu mice may differ from that occurring in humans, it is intriguing to apply insights obtained with this mouse model to the controversy regarding whether vertical transmission of HIV-1 in humans occurs in utero, intrapartum, or postpartum. Although HIV-1 was detected in fetal lymphoid organs (33, 34) , it is identified in less than half of the peripheral blood of HIV-l-infected newborns (35) (36) (37) . It is possible that after intrauterine transmission, HIV-1 localizes to lymphoid organs where its presence escapes detection. The high degree of lymphocyte proliferation occurring in the neonatal thymus makes it an attractive environment wherein substantial replication of HIV-1 can occur (1). Various T cell precursor populations in the thymus including the immature "triple negative" CD3-CD4 h~-CD8-T cell precursors and the more mature CD4 § CD8 + thymocytes are susceptible to HIV-1 infection (38). Our SCID-hu mouse model data indicate that human feral thymus can become infected after peripheral exposure to HIV-L Furthermore, after becoming infected with HIV-1 in the thymic environment, T ceils can migrate from the thymus and mediate peripheral dissemination of the HIV-1 infection. Taken together, these in vivo studies suggest that peripheral ceils infected with HIV-1 in utero may home to the thymus where they can infect thymocytes with HIV-1 and thereby mediate subsequent infection of peripheral lymphoid tissues. Examination of peripheral blood immediately after birth may not detect the high degree of HIV-1 replication occurring in the thymus, spleen, or LN. This is comparable to the dichotomy between the very active HIV-1 infection observed in LN and the low degree of HIV-1 infection seen in peripheral blood during the latent phase of HIV-1 infection in adults (4). Therefore, our SCID-hu mice may provide an improved modal for studying the role of prenatal and postnatal anti-HIV interventions on the prevention of vertical transmission of HIV-1.
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